This slide from Dr Rebecca Hahn is quite impressive. DurAVR shows considerably different performance compared to other valves but more significantly, near normal flow dynamics comparable to a pre disease healthy valve. Its not that we offer a superior product than the competitors, but the performance is near 'normal' performance as in a non diseased native valve.
Not advice, Just my unofficial opinion.
New video - Shaping TAVR of the Future: Anteris Tech’s DurAVR™ Transcatheter Heart Valve, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M | |||
| Open | High | Low | Value | Volume |
| $5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $6.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.27 | 200 | 1 |
View Market Depth
| Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |